| Pharmaceutical active ingredients: |
| Nylidrin Hydrochloride |
| Available forms, composition and doses of Dilydrin: |
| N / A |
| Dilydrin medical category: |
| Human:Vasodilatating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AA02 - BuphenineG02CA02 - Buphenine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Willvonseder & Marchesani |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Willlong | Nitroglycerin | Will-Pharma; BJC Trading |
| Willospon | Gelatin | Will-Pharma |
| Willospon Forte | Collagen | Will-Pharma |
| Actizyme | Poloxamer 338; Subtilisin A | Willvonseder & Marchesani |
| Aywet | Hydroxyethylcellulose; Poloxamer | Willvonseder & Marchesani |
| Marcocid | 1-Propanol; Isopropyl Alcohol | Willvonseder & Marchesani |
| Marcocid Farblos | 1-Propanol; Isopropyl Alcohol | Willvonseder & Marchesani |
| Marcocid Gefarbt | 1-Propanol; Isopropyl Alcohol | Willvonseder & Marchesani |
| Otalgan | Lidocaine Hydrochloride; Phenazone | Willvonseder & Marchesani |
| Panax | Acetaminophen; Butetamate Citrate; Caffeine | Willvonseder & Marchesani |